Juyeon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juyeon Kim has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Jiho Park
Department of Anesthesiology and Pain Medicine, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea
2 shared publications - Seounghun Lee
Department of Anesthesiology and Pain Medicine, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea
2 shared publications - Yeojung Kim
Department of Anesthesiology and Pain Medicine, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea
2 shared publications - Chan Noh
Department of Anesthesiology and Pain Medicine, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea
1 shared publication - Jinwoo Kim
Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, Daejeon 35015, Republic of Korea
1 shared publication - Mia Park
Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 17 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8062
Postoperative Opioid-Free Multistep Opiranserin Infusion Versus Fentanyl Patient-Controlled Analgesia After Breast or Minimally Invasive Gynecologic Surgery: A Retrospective Cohort Study
Background/Objectives: Women undergoing breast or gynecologic surgery face high postoperative nausea and vomiting (PONV) risk, which often prompts discontinuation of opioid patient-controlled analgesia (PCA). Since anticipated opioid use is an Apfel risk factor, we examined a postoperative opioid-free analgesic regimen using opiranserin, previously evaluated only as an adjunct. Methods: In this single-center retrospective cohort study, 150 women undergoing breast or minimally invasive gynecologic surgery received a multistep opiranserin infusion via a PCA pump without demand boluses (n = 77) or fentanyl demand bolus PCA (n = 73). The opiranserin infusion ended at 10 h; fentanyl PCA remained connected throughout. The primary outcome was resting numeric rating scale (NRS, 0–10) at 24 h, by which time the infusion had been complete for 14–15 h; secondary outcomes were post-anesthesia care unit (PACU) and 6 h NRS, PONV, and early discontinuation. Results: Resting NRS did not differ significantly during the infusion (PACU p = 0.965; 6 h p = 0.675), with a larger difference at 24 h. The adjusted 24 h difference was 0.58 points higher with opiranserin (95% CI, 0.04 to 1.12; p = 0.036) by covariance analysis on pre-treatment covariates and 0.55 (0.02 to 1.09) by inverse-probability-of-treatment weighting; the point estimates were below the minimal clinically important difference of 1 point, but the confidence intervals do not exclude a clinically relevant increase in pain, and the estimate was nonsignificant after adjusting for non-opioid adjuncts (p = 0.177). Moderate or severe pain at 24 h was more frequent with opiranserin (19.5% vs. 8.2%; adjusted odds ratio, 3.76; 95% CI, 1.34 to 11.82). PONV (9.1% vs. 11.0%), rescue analgesia (26.0% vs. 17.8%), and early discontinuation (10.4% vs. 9.6%) were similar. Rescue opioids were available to both groups but used by one fentanyl-group patient and by none receiving opiranserin. Conclusions: The regimen eliminated postoperative opioid exposure, with resting pain scores that differed by less than 1 NRS point on average, although a clinically relevant increase cannot be excluded. With coverage fixed at 10 h, the 24 h difference cannot be separated into a shortfall of the agent and a shortfall of coverage. The anticipated PONV reduction was not observed, possibly in the context of low event rates and routine antiemetic prophylaxis.
- 17 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 8062
Open AccessPostoperative Opioid-Free Multistep Opiranserin Infusion Versus Fentanyl Patient-Controlled Analgesia After Breast or Minimally Invasive Gynecologic Surgery: A Retrospective Cohort Study
Background/Objectives: Women undergoing breast or gynecologic surgery face high postoperative nausea and vomiting (PONV) risk, which often prompts discontinuation of opioid patient-controlled analgesia (PCA). Since anticipated opioid use is an Apfel risk factor, we examined a postoperative opioid-free analgesic regimen using opiranserin, previously evaluated only as an adjunct. Methods: In this single-center retrospective cohort study, 150 women undergoing breast or minimally invasive gynecologic surgery received a multistep opiranserin infusion via a PCA pump without demand boluses (n = 77) or fentanyl demand bolus PCA (n = 73). The opiranserin infusion ended at 10 h; fentanyl PCA remained connected throughout. The primary outcome was resting numeric rating scale (NRS, 0–10) at 24 h, by which time the infusion had been complete for 14–15 h; secondary outcomes were post-anesthesia care unit (PACU) and 6 h NRS, PONV, and early discontinuation. Results: Resting NRS did not differ significantly during the infusion (PACU p = 0.965; 6 h p = 0.675), with a larger difference at 24 h. The adjusted 24 h difference was 0.58 points higher with opiranserin (95% CI, 0.04 to 1.12; p = 0.036) by covariance analysis on pre-treatment covariates and 0.55 (0.02 to 1.09) by inverse-probability-of-treatment weighting; the point estimates were below the minimal clinically important difference of 1 point, but the confidence intervals do not exclude a clinically relevant increase in pain, and the estimate was nonsignificant after adjusting for non-opioid adjuncts (p = 0.177). Moderate or severe pain at 24 h was more frequent with opiranserin (19.5% vs. 8.2%; adjusted odds ratio, 3.76; 95% CI, 1.34 to 11.82). PONV (9.1% vs. 11.0%), rescue analgesia (26.0% vs. 17.8%), and early discontinuation (10.4% vs. 9.6%) were similar. Rescue opioids were available to both groups but used by one fentanyl-group patient and by none receiving opiranserin. Conclusions: The regimen eliminated postoperative opioid exposure, with resting pain scores that differed by less than 1 NRS point on average, although a clinically relevant increase cannot be excluded. With coverage fixed at 10 h, the 24 h difference cannot be separated into a shortfall of the agent and a shortfall of coverage. The anticipated PONV reduction was not observed, possibly in the context of low event rates and routine antiemetic prophylaxis.
- Open Access
Needle Trajectory Influences Foraminal Contrast Distribution and Pain Reduction Following Paramedian Cervical Interlaminar Epidural Steroid Injection: A Retrospective Study
Background and Objectives: Paramedian cervical interlaminar epidural steroid injection (CESI) is commonly used for cervical radicular pain and is considered safer than the transforaminal approach. However, its clinical effectiveness may be influenced by contrast distribution patterns, although these may not fully reflect actual drug delivery. This study aimed to evaluate the association between needle trajectory, foraminal or periradicular contrast distribution patterns, and short-term pain reduction following paramedian cervical interlaminar CESI. Materials and Methods: This single-center retrospective study included 109 patients who underwent paramedian cervical interlaminar CESI. Needle trajectory was classified as inward or outward. Contrast distribution was graded based on anteroposterior (AP) spread patterns. Pain intensity was assessed using a numeric rating scale (NRS) at baseline and 2 weeks after the procedure. Group comparisons were performed using Welch’s t-test and chi-square or Fisher’s exact test, as appropriate. Effect sizes were calculated using Cohen’s d and η2. Multivariable linear regression analysis was performed adjusting for age, sex, baseline NRS, and target level. Results: The outward trajectory group demonstrated a significantly higher proportion of Grade 2 contrast spread compared to the inward group (69.8% vs. 8.9%, p < 0.001). Higher AP contrast spread grades were associated with greater pain reduction (β = 0.83, 95% CI: 0.44–1.22, p < 0.001; η2 = 0.14). In addition, patients in the outward trajectory group showed greater NRS reduction than those in the inward group (2.96 vs. 1.71, mean difference: 1.25, 95% CI: 0.74–1.76, p < 0.001; Cohen’s d = 0.96). In multivariable analysis, needle trajectory remained significantly associated with pain reduction, whereas AP contrast spread grade was not independently associated. Conclusions: Needle trajectory was associated with contrast distribution patterns and short-term pain reduction following paramedian cervical interlaminar CESI. An outward-directed trajectory was associated with greater foraminal or periradicular contrast spread and greater pain reduction. These findings suggest that needle trajectory may represent a clinically relevant procedural factor influencing clinical outcomes.
Open AccessNeedle Trajectory Influences Foraminal Contrast Distribution and Pain Reduction Following Paramedian Cervical Interlaminar Epidural Steroid Injection: A Retrospective Study
Background and Objectives: Paramedian cervical interlaminar epidural steroid injection (CESI) is commonly used for cervical radicular pain and is considered safer than the transforaminal approach. However, its clinical effectiveness may be influenced by contrast distribution patterns, although these may not fully reflect actual drug delivery. This study aimed to evaluate the association between needle trajectory, foraminal or periradicular contrast distribution patterns, and short-term pain reduction following paramedian cervical interlaminar CESI. Materials and Methods: This single-center retrospective study included 109 patients who underwent paramedian cervical interlaminar CESI. Needle trajectory was classified as inward or outward. Contrast distribution was graded based on anteroposterior (AP) spread patterns. Pain intensity was assessed using a numeric rating scale (NRS) at baseline and 2 weeks after the procedure. Group comparisons were performed using Welch’s t-test and chi-square or Fisher’s exact test, as appropriate. Effect sizes were calculated using Cohen’s d and η2. Multivariable linear regression analysis was performed adjusting for age, sex, baseline NRS, and target level. Results: The outward trajectory group demonstrated a significantly higher proportion of Grade 2 contrast spread compared to the inward group (69.8% vs. 8.9%, p < 0.001). Higher AP contrast spread grades were associated with greater pain reduction (β = 0.83, 95% CI: 0.44–1.22, p < 0.001; η2 = 0.14). In addition, patients in the outward trajectory group showed greater NRS reduction than those in the inward group (2.96 vs. 1.71, mean difference: 1.25, 95% CI: 0.74–1.76, p < 0.001; Cohen’s d = 0.96). In multivariable analysis, needle trajectory remained significantly associated with pain reduction, whereas AP contrast spread grade was not independently associated. Conclusions: Needle trajectory was associated with contrast distribution patterns and short-term pain reduction following paramedian cervical interlaminar CESI. An outward-directed trajectory was associated with greater foraminal or periradicular contrast spread and greater pain reduction. These findings suggest that needle trajectory may represent a clinically relevant procedural factor influencing clinical outcomes.